Currently Enrolling
Trial Physician / Study Coordinator
Cindy Yancy-Spurgeon
Email Phone (423) 826-8003Site Name
Southeast Renal Research Institute
251 North Lylerly Street, Ste. 200, Chattanooga, TN 37404-2743
Find other locations for this trial:
Currently Enrolling
Eligibility Criteria
About the Drug
What is involved for the patient
Target Enrollment
Up to 125 patients FSGS / TR-MCD or DN are planned to be enrolled into the study.
Estimated End Date
TBC